Skip to main navigation
Skip to search
Skip to main content
Icahn School of Medicine at Mount Sinai Home
Help & FAQ
Home
Profiles
Research units
Publications & Research Outputs
Press/Media
Search by expertise, name or affiliation
Loracarbef: Sinus tissue penetration after single dose administration
David R. Edelstein
, Charles P. Kimmelman
Research output
:
Contribution to journal
›
Article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Loracarbef: Sinus tissue penetration after single dose administration'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Sinus
100%
Single-dose Treatment
100%
Tissue Penetration
100%
Loracarbef
100%
Tissue Level
50%
Sinusitis
50%
Antibiotic Use
25%
Therapeutic Efficacy
25%
Body Fluids
25%
Body Tissues
25%
Tissue Concentration
25%
Oral Administration
25%
Mucosal Tissues
25%
Antibiotic Treatment
25%
Curative Agent
25%
Mean Inhibitory Concentration
25%
Pharmacology, Toxicology and Pharmaceutical Science
Sinusitis
100%
Loracarbef
100%
Combination Therapy
50%
Antibiotics
50%
Diseases
50%
Oral Administration
50%
Veterinary Science and Veterinary Medicine
Blood Plasma
100%
Diseases
100%